Search research articles
Contact Us
Filters
Showing results (191-200 of 217) with videos related to
Page
of 22
Sort By:
Chemistry & Biology
|
November 5, 2013
Next-generation NAMPT inhibitors identified by sequential high-throughput phenotypic chemical and functional genomic screens
Christina J Matheny, Michael C Wei, Michael C Bassik, et al.
Leukemia & Lymphoma
|
June 5, 2024
Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial
Vikas Gupta, Abdulraheem Yacoub, Ruben A Mesa, et al.
Journal of Neurointerventional Surgery
|
August 14, 2020
The professional and personal impact of the coronavirus pandemic on US neurointerventional practices: a nationwide survey
Kyle M Fargen, Thabele M Leslie-Mazwi, Richard P Klucznik, et al.
The Lancet. Haematology
|
September 12, 2024
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial
Claire N Harrison, Ruben Mesa, Moshe Talpaz, et al.
Journal of the American College of Cardiology
|
March 4, 2017
Effect of Current Dietary Recommendations on Weight Loss and Cardiovascular Risk Factors
David J A Jenkins, Beatrice A Boucher, Fredrick D Ashbury, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
July 9, 2024
Canada's approach to SARS-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics
Sheila F O'Brien, Michael Asamoah-Boaheng, Brian Grunau, et al.
Research Square
|
June 12, 2025
Brain-cognition relationships and treatment outcome in treatment-resistant late-life depression
Aristotle Voineskos, Peter Zhukovsky, Meryl Butters, et al.
Pediatric Blood & Cancer
|
November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group
Wanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2018
Chimeric Antigen Receptor T-Cell Therapy
Ndiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 217) with videos related to
Sort By:
Page
of 22
Chemistry & Biology
|
November 5, 2013
Next-generation NAMPT inhibitors identified by sequential high-throughput phenotypic chemical and functional genomic screens
Christina J Matheny, Michael C Wei, Michael C Bassik, et al.
Leukemia & Lymphoma
|
June 5, 2024
Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial
Vikas Gupta, Abdulraheem Yacoub, Ruben A Mesa, et al.
Journal of Neurointerventional Surgery
|
August 14, 2020
The professional and personal impact of the coronavirus pandemic on US neurointerventional practices: a nationwide survey
Kyle M Fargen, Thabele M Leslie-Mazwi, Richard P Klucznik, et al.
The Lancet. Haematology
|
September 12, 2024
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial
Claire N Harrison, Ruben Mesa, Moshe Talpaz, et al.
Journal of the American College of Cardiology
|
March 4, 2017
Effect of Current Dietary Recommendations on Weight Loss and Cardiovascular Risk Factors
David J A Jenkins, Beatrice A Boucher, Fredrick D Ashbury, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
July 9, 2024
Canada's approach to SARS-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics
Sheila F O'Brien, Michael Asamoah-Boaheng, Brian Grunau, et al.
Research Square
|
June 12, 2025
Brain-cognition relationships and treatment outcome in treatment-resistant late-life depression
Aristotle Voineskos, Peter Zhukovsky, Meryl Butters, et al.
Pediatric Blood & Cancer
|
November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group
Wanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2018
Chimeric Antigen Receptor T-Cell Therapy
Ndiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.
Page
of 22